Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WorldHeart was a medical technology company dedicated to the development and commercialization of mechanical circulatory support systems for patients with advanced heart failure. The company's flagship product, the Levacor Ventricular Assist Device (VAD), was a rotary pump that utilized magnetic levitation technology to suspend the rotor, thereby reducing friction and potential blood damage. WorldHeart's portfolio also included the Novacor VAD, a pulsatile pump acquired from Edwards Lifesciences. The company's devices were designed for both bridge-to-transplant and destination therapy applications. In 2012, WorldHeart was acquired by HeartWare International, which was subsequently acquired by Medtronic in 2016.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WorldHeart.